Increased serum kallistatin levels in type 1 diabetes patients with vascular complications

Autoria(s): Jenkins, Alicia J; McBride, Jeffrey D; Januszewski, Andrzej S; Karschimkus, Connie S; Zhang, Bin; O'Neal, David N; Nelson, Craig L; Chung, Jasmine S; Harper, C Alex; Lyons, Timothy J; Ma, Jian-Xing
Data(s)

2010
Resumo

Kallistatin, a serpin widely produced throughout the body, has vasodilatory, anti-angiogenic, anti-oxidant, and anti-inflammatory effects. Effects of diabetes and its vascular complications on serum kallistatin levels are unknown.
Identificador

http://pure.qub.ac.uk/portal/en/publications/increased-serum-kallistatin-levels-in-type-1-diabetes-patients-with-vascular-complications(dd3c81c9-d3e4-4034-ba06-d1d81ce9697e).html

http://dx.doi.org/10.1186/2040-2384-2-19
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Jenkins , A J , McBride , J D , Januszewski , A S , Karschimkus , C S , Zhang , B , O'Neal , D N , Nelson , C L , Chung , J S , Harper , C A , Lyons , T J & Ma , J-X 2010 , ' Increased serum kallistatin levels in type 1 diabetes patients with vascular complications ' Journal of angiogenesis research , vol 2 , pp. 19 . DOI: 10.1186/2040-2384-2-19
Tipo

article
Acesso ao item digital